NIH-funded research R01 grant

Using AI to improve glucose control in diabetes management

Official title: SCH: Integrating AI and System Engineering for Glucose Regulation in Diabetes

Funded at Illinois Institute of Technology · NIH-10904740 · Data updated 2026-11-12

This study is testing a smart insulin delivery system that uses technology to automatically adjust insulin based on your real-time glucose levels and daily activities, making it easier for people with diabetes to manage their blood sugar without having to do it all manually.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionIllinois Institute of Technology
NIH-funded
Lab location1 site (Chicago, United States)
Project startSeptember 19, 2022
Project endJuly 31, 2026
Funding year2024
Award (this year)$285,717
NIH project number5R01DK135116-03
Project IDNIH-10904740 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with Type 1 diabetes who experience challenges in managing their blood glucose levels.

Less likely to help

Patients with Type 2 diabetes or those who do not require insulin therapy may not benefit from this research.

What this research studies

This research aims to create an advanced automated insulin delivery system, known as a multivariable automated insulin delivery (mvAID) system, which utilizes artificial intelligence and systems engineering. By analyzing real-time data from continuous glucose monitors, insulin pumps, and wearable activity trackers, the system will automatically adjust insulin delivery without requiring manual input from users. This innovative approach seeks to address the challenges posed by meals, physical activities, psychological stress, and sleep irregularities on blood glucose levels, ultimately providing a more seamless management experience for individuals with diabetes.

Why it matters

Potential benefit: If successful, this research could lead to improved glucose regulation and a better quality of life for patients with diabetes.

How similar studies have gone: Previous research has shown promise in using automated insulin delivery systems, but this approach integrates novel AI techniques, making it a potentially groundbreaking advancement.

Where this research is happening

  • Illinois Institute of Technology
    Chicago, United States
    Active

Researchers

  • Principal investigator: Cinar, Ali — Illinois Institute of Technology
  • Study coordinator: Cinar, Ali

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.